SCHEMBL23925332

SCHEMBL23925332

COC(=O)c1cc(Br)cc2[nH]c(Cc3ccccc3)nc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNASEH1 O60930 1/20 0.50
DHODH Q02127 1/20 0.46
BRD4 O60885 1/20 0.44
CREBBP Q92793 1/20 0.44
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
TSHR P16473 2/20 0.41
GAA P10253 2/20 0.41
PKM P14618 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41
BLM P54132 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26631562 0.82 PTGES (0.40) DHODHALDH1A1KDM4EMAPTPTGES
SCHEMBL30139028 0.82 PTGES (0.40) DHODHALDH1A1KDM4EMAPTPTGES
SCHEMBL26631528 0.80 RNASEH1 (0.43) RNASEH1DHODHBRD4CREBBPPTGES
SCHEMBL30138979 0.80 RNASEH1 (0.43) RNASEH1DHODHBRD4CREBBPPTGES
SCHEMBL20482842 0.79 DHODH (0.44) DHODHMAPT
SCHEMBL30242145 0.79 DHODH (0.44) DHODHMAPT
SCHEMBL26631541 0.75 DHODH (0.38) DHODHALDH1A1KDM4EHPGDCRHBP
SCHEMBL30139014 0.75 DHODH (0.38) DHODHALDH1A1KDM4EHPGDCRHBP
SCHEMBL18152681 0.74 GRIN1 (0.47) BRD4ALDH1A1KDM4ETSHRGAA
SCHEMBL20477252 0.74 RNASEH1 (0.68) RNASEH1ALDH1A1TSHRGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348398-A1 Benzimidazole derivatives HOFFMANN-LA ROCHE INC. (US) 2023-11-02 US disclosed
EP-4136077-A1 BENZIMIDAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2023-02-22 EP disclosed
CN-115485266-A Benzimidazole derivatives 豪夫迈·罗氏有限公司 2022-12-16 CN disclosed
WO-2021209484-A1 BENZIMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348398-A1 Benzimidazole derivatives HRH4, H1-4, CYP3A4 RNASEH1 1006/4885DHODH 976/4885BRD4 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.